Researchers identify key protein in cancer drug resistance
April 5, 2017Research and Development Cancer, university of salford
A University of Salford research team has identified a gene which they believe is one of the leading causes of …
GSK hit by recall of 600,000 inhalers
April 5, 2017Manufacturing and Production, Research and Development FDA, GSK, Ventolin
The FDA has released that GSK would be voluntarily recalling close to 600,000 of its Ventolin asthma inhalers across the …
Joanne Estell joins Shield Therapeutics as CFO
April 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Shield Therapeutics has announced that it has recruited Joanne Estell as its new CFO and board member; she will step …
Common antibiotic shows promise as novel PTSD treatment
April 5, 2017Research and Development PTSD, UCL, antibiotic, doxycycline
Research coming out of University College London (UCL) and the University of Zurich has indicated that common antibiotic doxycycline could …
NICE turns down Shire’s pancreatic cancer treatment
April 4, 2017Manufacturing and Production, Sales and Marketing NICE, Pancreatic cancer, Shire
NICE has announced its intention not to recommend the NHS use of Shire’s Onivyde (pegylated liposomal irinotecan) for the treatment …
Mylan hit with fresh lawsuit over EpiPen pricing
April 4, 2017Manufacturing and Production, Sales and Marketing Mylan, epipen, pricing
Just as it faces worldwide reports that over 80,000 of its EpiPens do not function properly and as the FDA …
Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug
April 4, 2017Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva
Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …
Sanofi to pay $20m fine for overcharging US veterans
April 4, 2017Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US
Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
Novartis combo expands into lung cancer with EU approval
April 4, 2017Manufacturing and Production, Sales and Marketing NSCLC, Novartis, Tafinlar, mekinist
Novartis has announced that its Tafinlar (dabrafenib) and Mekinist (trametinib) drug combo has been approved by the European Commission (EC) …
Vencerx Therapeutics ring the changes appointing ex-Pfizer Director as CEO
April 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vencerx therapeutics
Vencerx Therapeutics, a biotech focused on developing treatments for neurodevelopmental disorders, has announced the appointment of Robert Ring as CEO. …
Behind Rare Disease Day 2017
April 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Rare Disease Day, rare disease
Rare Disease Day falls on the last day of February, meaning every four years it occurs on a leap year, …
Finger-prick blood test could help with depression medication
April 3, 2017Research and Development, Sales and Marketing
Researchers from the University of Texas Southwestern Medical Center have found that simple finger-prick blood test could reveal the most …
Immune system influences immunotherapy effectiveness, research shows
April 3, 2017Research and Development, Sales and Marketing immunotherapy, nivolumab, opdivo
Preliminary research conducted at the University of Pittsburgh Cancer Institute (UPCI) has discovered a link between levels of certain immune …
Pfizer secures expanded approval for Ibrance
April 3, 2017Sales and Marketing Pfizer, ibrance
Pfizer has announced that FDA has approved its supplemental New Drug Application (sNDA) for Ibrance, meaning that the drug is …
FDA issues US-wide recall of Mylan’s EpiPen
April 3, 2017Medical Communications, Sales and Marketing FDA, Mylan, epipen
After recent reports of around 80,000 defective EpiPen’s across Australia, New Zealand, Japan, Norway, Denmark, Finland and Ireland, the FDA …
Astellas lines up Ogeda for acquisition in $853 million deal
April 3, 2017Sales and Marketing Astellas, Ogeda SA, menopause
Astellas, based in Tokyo, has announced that it has agreed a deal to acquire Belgium-based Ogeda SA. The deal will …
Crunch Time: The Impact of Serialisation Requirements on Packaging Operations
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI services
Introduction More than three years have passed since the US federal government signed the Drug Supply Chain Security Act (DSCSA) …
Takeda lays off more than half of Ariad’s US staff
March 31, 2017Medical Communications Ariad Pharmaceuticals, Takeda
Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …
Top Ten most popular articles on Pharmafile.com this week
March 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …
FDA approves first-ever atopic dermatitis biologic treatment
March 31, 2017Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic
Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
